Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.12 SGD | +50.00% | +50.00% | +22.45% |
Apr. 15 | Pharmesis’ Attributable Loss for 2023 Widens | MT |
Apr. 15 | Pharmesis International Ltd. Announces the Retirement of Ms. Lin Yimin as a Director | CI |
Sales 2022 | 50.37M 6.95M 9.47M | Sales 2023 | 45.64M 6.3M 8.58M | Capitalization | 14.45M 1.99M 2.72M |
---|---|---|---|---|---|
Net income 2022 | -3M -414K -564K | Net income 2023 | -4M -552K -752K | EV / Sales 2022 | 0.19 x |
Net cash position 2022 | 3.18M 440K 599K | Net Debt 2023 | 7.05M 973K 1.33M | EV / Sales 2023 | 0.47 x |
P/E ratio 2022 |
-3.63
x | P/E ratio 2023 |
-2.79
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 22.66% |
1 day | +50.00% | ||
1 week | +50.00% | ||
Current month | -8.40% | ||
1 month | -8.40% | ||
3 months | +34.83% | ||
6 months | +39.53% | ||
Current year | +22.45% |
Managers | Title | Age | Since |
---|---|---|---|
Xue Dan Wu
CEO | Chief Executive Officer | - | 04-04-15 |
Hui Yee Cheok
SEC | Corporate Secretary | - | 22-05-29 |
Chan Hoe Liang
AUD | Comptroller/Controller/Auditor | - | 16-05-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Heng Ching Chew
CHM | Chairman | 73 | 05-11-08 |
Xue Dan Wu
CEO | Chief Executive Officer | - | 04-04-15 |
Yimin Lin
BRD | Director/Board Member | 35 | 23-07-30 |
1st Jan change | Capi. | |
---|---|---|
+22.45% | 1.62M | |
+25.83% | 653B | |
+27.00% | 556B | |
-6.76% | 354B | |
+20.34% | 331B | |
+3.00% | 296B | |
+13.09% | 233B | |
+5.46% | 201B | |
-9.61% | 193B | |
-6.26% | 144B |
- Stock Market
- Equities
- BFK Stock